Ontology highlight
ABSTRACT:
SUBMITTER: Yaribeygi H
PROVIDER: S-EPMC8263148 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
Yaribeygi Habib H Farrokhi Farin Rashid FR Abdalla Mohammed Altigani MA Sathyapalan Thozhukat T Banach Maciej M Jamialahmadi Tannaz T Sahebkar Amirhossein A
Journal of diabetes research 20210630
Glucagon-like peptide-1 receptor (GLP-1R) agonists are a class of newly introduced antidiabetic medications that potentially lower blood glucose by several molecular pathways. DPP-4 inhibitors are the other type of novel antidiabetic medications which act by preventing GLP-1 inactivation and thereby increasing the activity levels of GLP-1, leading to more glucose-induced insulin release from islet <i>β</i>-cells and suppression of glucagon release. Most patients with diabetes have concurrent hyp ...[more]